OnKure Therapeutics, Inc. (OKUR)

NGM – Real Time Price. Currency in USD

4.04

-0.05 (-1.22%)

Market open: Aug 12, 2026, 10:15 AM EDT

4.09

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

04.08.2026

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

-- Executing IND-enabling activities for next-generation PI3Kα pan-mutant selective candidates OKI-345 in breast cancer and OKI-355 in vascular anomalies, with IND submissions planned for 1H 2027

Videos

No Data

There is no data to display

Press releases

04.08.2026

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

-- Executing IND-enabling activities for next-generation PI3Kα pan-mutant selective candidates OKI-345 in breast cancer and OKI-355 in vascular anomalies, with IND submissions planned for 1H 2027

OnKure Therapeutics, Inc. (OKUR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

OnKure Therapeutics, Inc. (OKUR)

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Videos

No Data

Press releases

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Videos

No Data

Press releases

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Search stocks

OnKure Therapeutics, Inc. (OKUR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

OnKure Therapeutics, Inc. (OKUR)

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Videos

No Data

Press releases

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Videos

No Data

Press releases

OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights